Doctors and drug costs
Physicians infrequently communicate with patients about the cost of new medication prescriptions, according to a study in the November issue of the American Journal of Managed Care. Researchers from the University of California assessed patient and physician surveys and transcriptions of 185 office visits from 1999. "For one third of newly prescribed medications, physicians discussed an aspect of acquisition, including cost and insurance coverage for 12%, logistics of obtaining medications for 18%, and medication supply for 9%," Derjung Tarn et al. state. "Interventions should target improving physician knowledge about helping patients achieve affordable medication regimens, as well as stressing the importance of recognizing and addressing cost and acquisition issues with patients," the authors conclude...
You may also be interested in...
Zydus Cadila is to begin testing a three-dose recombinant DNA vaccine candidate in Phase III Indian trials, which might enter late-stage development ahead of Inovio and AnGes. The company promised to provide 100-150 million doses by end of 2021 at the J.P. Morgan Conference, though adherence could be a roadblock.
Sun Pharma’s founder and MD shares with Scrip his views on some key big picture issues, including leveraging pandemic-related regulatory experience for urgently needed products, expectations in the US market, the outlook for M&A, and the potential of e-pharmacies in India.
India is allowing importers and manufacturers of certain devices – for whom new licensing requirements came into effect on 1 January – to continue marketing their products for six months if they have already applied for a license. See what Rajiv Nath from the Association of Indian Medical Device Industry (AiMeD) said about it here.